REGN
REGN
US75886F1075
Regeneron Pharmaceuticals, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
76.86B EUR
64.31B EUR
81.14B EUR
81.6B EUR
Enterprise Value
68.56B EUR
64.56B EUR
80.88B EUR
81.19B EUR
Valuation Multiples
Trailing P/E
18.46x
14.86x
18.34x
22.08x
Forward P/E
12.11x
--
--
--
Price to Sales
4.95x
4.14x
5.44x
7.21x
Price to Book
2.36x
2.03x
2.58x
2.61x
EV/Revenue
4.41x
4.16x
5.42x
7.18x
EV/EBITDA
14.58x
11.87x
15.77x
19.88x
Price to FCF (P/FCF)
25.07x
17.99x
21.4x
27.28x
EV/FCF
22.37x
18.06x
21.34x
27.14x
FCF Yield
3.99%
5.56%
4.67%
3.67%
ende